CN103180293A - 23-炔-维生素d3衍生物 - Google Patents
23-炔-维生素d3衍生物 Download PDFInfo
- Publication number
- CN103180293A CN103180293A CN2011800515197A CN201180051519A CN103180293A CN 103180293 A CN103180293 A CN 103180293A CN 2011800515197 A CN2011800515197 A CN 2011800515197A CN 201180051519 A CN201180051519 A CN 201180051519A CN 103180293 A CN103180293 A CN 103180293A
- Authority
- CN
- China
- Prior art keywords
- alkynes
- cholestatriene
- triol
- open loop
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510228060.3A CN104829510B (zh) | 2010-10-25 | 2011-10-24 | 23-炔-维生素d3衍生物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010238524 | 2010-10-25 | ||
JP2010-238524 | 2010-10-25 | ||
PCT/JP2011/074414 WO2012057068A1 (ja) | 2010-10-25 | 2011-10-24 | 23-イン-ビタミンd3誘導体 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510228060.3A Division CN104829510B (zh) | 2010-10-25 | 2011-10-24 | 23-炔-维生素d3衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103180293A true CN103180293A (zh) | 2013-06-26 |
CN103180293B CN103180293B (zh) | 2015-06-17 |
Family
ID=45993776
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180051519.7A Expired - Fee Related CN103180293B (zh) | 2010-10-25 | 2011-10-24 | 23-炔-维生素d3衍生物 |
CN201510228060.3A Expired - Fee Related CN104829510B (zh) | 2010-10-25 | 2011-10-24 | 23-炔-维生素d3衍生物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510228060.3A Expired - Fee Related CN104829510B (zh) | 2010-10-25 | 2011-10-24 | 23-炔-维生素d3衍生物 |
Country Status (21)
Country | Link |
---|---|
US (2) | US9006220B2 (zh) |
EP (1) | EP2634171B8 (zh) |
JP (1) | JP5738307B2 (zh) |
KR (1) | KR101853518B1 (zh) |
CN (2) | CN103180293B (zh) |
AR (1) | AR083541A1 (zh) |
AU (1) | AU2011321624B2 (zh) |
BR (1) | BR112013009647A2 (zh) |
CA (1) | CA2815501C (zh) |
DK (1) | DK2634171T3 (zh) |
ES (1) | ES2541719T3 (zh) |
HK (2) | HK1184133A1 (zh) |
HU (1) | HUE025554T2 (zh) |
IL (1) | IL225630A0 (zh) |
MX (1) | MX347126B (zh) |
PL (1) | PL2634171T3 (zh) |
PT (1) | PT2634171E (zh) |
RU (1) | RU2558362C2 (zh) |
SG (1) | SG189427A1 (zh) |
TW (1) | TWI503120B (zh) |
WO (1) | WO2012057068A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013162047A1 (ja) * | 2012-04-24 | 2013-10-31 | 帝人ファーマ株式会社 | 二次性副甲状腺機能亢進症治療剤 |
JP2020143008A (ja) * | 2019-03-05 | 2020-09-10 | 達也 楠堂 | 新規褐色脂肪細胞分化誘導剤 |
CN114681467B (zh) * | 2022-03-30 | 2024-03-12 | 南通华山药业有限公司 | 一种阿法骨化醇杂环酯类衍生物在制备抗肿瘤药物中的应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
EP0808832A2 (en) * | 1996-05-23 | 1997-11-26 | F. Hoffmann-La Roche Ag | Fluorinated vitamin D3 analogs |
CN1175573A (zh) * | 1996-05-23 | 1998-03-11 | 弗·哈夫曼-拉罗切有限公司 | 维生素d3类似物 |
US20010051617A1 (en) * | 1997-07-21 | 2001-12-13 | Wisconsin Alumni Research Foundation | 18-substituted-19-nor-vitamin D compounds |
US20020045772A1 (en) * | 1998-04-10 | 2002-04-18 | Chugai Seiyaku Kabushiki Kaisha | Vitamin D derivative having substituent at 2beta-position |
US20020094972A1 (en) * | 1998-02-24 | 2002-07-18 | Chugai Seiyaku Kabushiki Kaisha | 24-hydroxy vitamin D derivatives |
CN101106985A (zh) * | 2004-09-24 | 2008-01-16 | 拜奥艾克塞尔股份公司 | 20-环烷基,26,27-烷基/卤代烷基维生素d3化合物及其使用方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
AU666563B2 (en) * | 1992-08-07 | 1996-02-15 | Wisconsin Alumni Research Foundation | Preparation of 19-nor-vitamin D compounds |
GB9611603D0 (en) | 1996-06-04 | 1996-08-07 | Leo Pharm Prod Ltd | Chemical compounds |
AU743399B2 (en) | 1997-06-25 | 2002-01-24 | Teijin Limited | Vitamin d3 derivatives and remedies for inflammatory respiratory diseases prepared from the same |
US5939406A (en) * | 1997-07-21 | 1999-08-17 | Wisconsin Alumni Research Foundation | 18-substituted-19-nor-vitamin D compounds |
ATE401303T1 (de) * | 1998-02-24 | 2008-08-15 | Chugai Pharmaceutical Co Ltd | Verfahren zur herstellung von ed-71 |
WO2001062723A1 (fr) * | 2000-02-28 | 2001-08-30 | Chugai Seiyaku Kabushiki Kaisha | DERIVES DE VITAMINE D COMPORTANT DES SUBSTITUANTS EN POSITION 2$g(a) |
JP2009013154A (ja) * | 2006-09-29 | 2009-01-22 | Teijin Pharma Ltd | 2−置換−14−エピ−プレビタミンd3誘導体 |
-
2011
- 2011-10-24 US US13/880,637 patent/US9006220B2/en not_active Expired - Fee Related
- 2011-10-24 ES ES11836202.9T patent/ES2541719T3/es active Active
- 2011-10-24 PL PL11836202T patent/PL2634171T3/pl unknown
- 2011-10-24 WO PCT/JP2011/074414 patent/WO2012057068A1/ja active Application Filing
- 2011-10-24 BR BR112013009647A patent/BR112013009647A2/pt not_active Application Discontinuation
- 2011-10-24 SG SG2013028584A patent/SG189427A1/en unknown
- 2011-10-24 AR ARP110103926A patent/AR083541A1/es not_active Application Discontinuation
- 2011-10-24 RU RU2013124033/04A patent/RU2558362C2/ru not_active IP Right Cessation
- 2011-10-24 AU AU2011321624A patent/AU2011321624B2/en not_active Ceased
- 2011-10-24 CN CN201180051519.7A patent/CN103180293B/zh not_active Expired - Fee Related
- 2011-10-24 CN CN201510228060.3A patent/CN104829510B/zh not_active Expired - Fee Related
- 2011-10-24 PT PT118362029T patent/PT2634171E/pt unknown
- 2011-10-24 CA CA2815501A patent/CA2815501C/en not_active Expired - Fee Related
- 2011-10-24 JP JP2012540840A patent/JP5738307B2/ja not_active Expired - Fee Related
- 2011-10-24 DK DK11836202.9T patent/DK2634171T3/en active
- 2011-10-24 KR KR1020137010316A patent/KR101853518B1/ko active IP Right Grant
- 2011-10-24 TW TW100138462A patent/TWI503120B/zh not_active IP Right Cessation
- 2011-10-24 EP EP11836202.9A patent/EP2634171B8/en active Active
- 2011-10-24 MX MX2013004389A patent/MX347126B/es active IP Right Grant
- 2011-10-24 HU HUE11836202A patent/HUE025554T2/en unknown
-
2013
- 2013-04-08 IL IL225630A patent/IL225630A0/en unknown
- 2013-10-10 HK HK13111437.3A patent/HK1184133A1/zh not_active IP Right Cessation
-
2015
- 2015-02-03 US US14/612,781 patent/US9079843B2/en not_active Expired - Fee Related
- 2015-12-07 HK HK15112013.1A patent/HK1211281A1/zh not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
EP0808832A2 (en) * | 1996-05-23 | 1997-11-26 | F. Hoffmann-La Roche Ag | Fluorinated vitamin D3 analogs |
CN1175573A (zh) * | 1996-05-23 | 1998-03-11 | 弗·哈夫曼-拉罗切有限公司 | 维生素d3类似物 |
US20010051617A1 (en) * | 1997-07-21 | 2001-12-13 | Wisconsin Alumni Research Foundation | 18-substituted-19-nor-vitamin D compounds |
US20020094972A1 (en) * | 1998-02-24 | 2002-07-18 | Chugai Seiyaku Kabushiki Kaisha | 24-hydroxy vitamin D derivatives |
US20020045772A1 (en) * | 1998-04-10 | 2002-04-18 | Chugai Seiyaku Kabushiki Kaisha | Vitamin D derivative having substituent at 2beta-position |
CN101106985A (zh) * | 2004-09-24 | 2008-01-16 | 拜奥艾克塞尔股份公司 | 20-环烷基,26,27-烷基/卤代烷基维生素d3化合物及其使用方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO174547B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dideh ydrovitamin-d3/n -derivater | |
AU707942B2 (en) | New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents | |
JPH04506965A (ja) | 新規ビタミンd類似体 | |
US10053415B2 (en) | Synthesis of a substituted indene derivative | |
SK45895A3 (en) | 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparation containing these derivatives and their use in the manufacture of medicines | |
EP2283023A2 (en) | Bryostatin analogues and methods of making and using thereof | |
CN103180293B (zh) | 23-炔-维生素d3衍生物 | |
EP2780336B1 (en) | Structural variants of mycolactones for use in modulating inflammation, immunity and pain | |
US6043385A (en) | Vitamin D derivatives | |
HU190530B (en) | Process for producing 7-oxabicyclo-heptane-substituted analogues of prostaglandines | |
JPH05501718A (ja) | 側鎖同族体ビタミン―d―誘導体、その製造法ならびに該誘導体を含有する、過増殖を示す疾病を治療するための製薬学的調製剤 | |
Plonska-Ocypa et al. | 13-Methyl-substituted des-C, D analogs of (20S)-1α, 25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation | |
JP2003506435A (ja) | 新規ビタミンd類縁体 | |
WO2006019169A1 (ja) | 3-エピビタミンd3誘導体およびそれを用いる治療剤 | |
WO1996026891A1 (fr) | Derives de cyclopentene substitues et leur procede de preparation | |
WO2013162047A1 (ja) | 二次性副甲状腺機能亢進症治療剤 | |
ES2946255A1 (es) | Sila-analogos de compuestos de vitamina d, metodo de produccion de dichos compuestos y usos de los mismos | |
Saito et al. | 23-yne-vitamin D 3 derivative | |
JP2004307420A (ja) | 細胞死抑制作用を有する化合物、およびその製造方法 | |
EP2253636A1 (en) | Neuronal cell death inhibitor | |
JP2009191032A (ja) | 15−置換ビタミンd3誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1184133 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1184133 Country of ref document: HK |
|
TR01 | Transfer of patent right |
Effective date of registration: 20161220 Address after: Osaka City, Osaka of Japan Patentee after: Teijin Ltd. Address before: Tokyo, Japan, Japan Patentee before: Teijin Pharma Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150617 Termination date: 20191024 |
|
CF01 | Termination of patent right due to non-payment of annual fee |